MedX Health (CVE:MDX) Reaches New 12-Month High at $0.09

MedX Health Corp (CVE:MDX) shares hit a new 52-week high on Friday . The stock traded as high as C$0.09 and last traded at C$0.09, with a volume of 320751 shares trading hands. The stock had previously closed at C$0.08.

MedX Health Stock Performance

The company has a fifty day simple moving average of C$0.06 and a two-hundred day simple moving average of C$0.06. The company has a market capitalization of C$24.89 million, a price-to-earnings ratio of -3.17 and a beta of 1.21.

MedX Health (CVE:MDX) last issued its quarterly earnings results on Wednesday, March 6th. The company reported C($0.53) earnings per share for the quarter. The business had revenue of C$26.41 million during the quarter. As a group, analysts expect that MedX Health Corp will post 0.0029191 EPS for the current year.

MedX Health Company Profile

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.